Infective endocarditis from IV drug use tied to hemorrhagic stroke
April 27, 2021
The incidence of patients with IVDU-associated endocarditis increased 630% from 2014 to 2018.
Lower target LDL-C cuts risk of CV events in ischemic stroke patients
April 23, 2021
Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?
Stroke is ‘not a common complication’ in COVID-19
April 20, 2021
Among the sickest of COVID patients – those admitted to an ICU – researchers found that stroke was not a common complication.
Watch for abnormal movements in hospitalized COVID-19 patients
April 19, 2021
“A heightened awareness of abnormal eye movements, or subtle facial tremoring, may be the first steps in recognizing potentially dangerous neurologic manifestations,” the researchers said.
How some COVID-19 vaccines could cause rare blood clots
April 14, 2021
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
Encephalopathy common, often lethal in hospitalized patients with COVID-19
March 29, 2021
Toxic metabolic encephalopathy was associated with a 24% higher risk of in-hospital death.
Late-window stroke thrombolysis not linked to clot migration
March 3, 2021
This is the first randomized controlled study to assess the effect of thrombolysis on clot migration and accessibility in an extended time window.
Neurologic disorders ubiquitous and rising in the U.S.
March 2, 2021
Most of the rise in disease burden could be attributed to population aging, while age-standardized figures showed stroke and dementias to be level or declining, offering hope that prevention measures may be having an effect.
Loss of smell lingers post COVID-19
February 24, 2021
The fact that the sense of smell had not returned to normal for half the participants so long after being infected is “novel and quite striking.”
When the X-Waiver gets X’ed: Implications for hospitalists
February 17, 2021
Hospitalists can be leaders in further adopting buprenorphine as standard of care for people with OUD.